Option
CAVENEY BRIAN J officer: EVP, President of Diagnostics officer: EVP, President of Diag..
Common Stock 2,010 N/A N/A Option
EISENBERG GLENN A officer: Chief Financial Officer, EVP officer: Chief Financial Office..
Restricted Stock Unit 9,024 N/A N/A Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Common Stock 2,007 N/A N/A Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Restricted Stock Unit 2,007 N/A N/A Option
EISENBERG GLENN A officer: Chief Financial Officer, EVP officer: Chief Financial Office..
Common Stock 9,024 N/A N/A Option
SCHECHTER ADAM H director, officer: President & CEO director, officer: President & ..
Common Stock 2,007 N/A N/A Option
SCHECHTER ADAM H director, officer: President & CEO director, officer: President & ..
Restricted Stock Unit 2,007 N/A N/A Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Non-qualified Stock Options 4,500 $84.86 $381,870 Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 4,500 $296.78 $1,335,510 Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Non-qualified Stock Options 4,500 $84.86 $381,870 Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 4,500 $84.86 $381,870 Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Non-qualified Stock Options 4,500 $84.86 $381,870 Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Common Stock 15 $297.61 $4,464 Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Restricted Stock Unit 50 N/A N/A Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Restricted Stock Unit 50 N/A N/A Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Non-qualified Stock Options 4,500 N/A N/A Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 4,500 N/A N/A Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 4,500 N/A N/A Sale
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Common Stock 2,500 $276.55 $691,375 Sale
BELINGARD JEAN-LUC director director
Common Stock 2,600 $98.49 $256,074 Option
BELINGARD JEAN-LUC director director
Common Stock 2,600 $98.49 $256,074 Option
BELINGARD JEAN-LUC director director
Non-qualified Stock Options 2,600 $98.49 $256,074 Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Common Stock 1,010 N/A N/A Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Restricted Stock Unit 1,010 N/A N/A Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 812 $251.88 $204,527 Sale
SCHROEDER MARK S officer: EVP, President-Diagnostics Lab officer: EVP, President-Diagnos..
Common Stock 667 $251.88 $168,004 Sale
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Common Stock 2,317 N/A N/A Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Common Stock 2,166 $164.55 $356,415 Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Non-qualified Stock Options 2,166 $164.55 $356,415 Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Non-qualified Stock Options 2,166 $91.26 $197,658 Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Common Stock 2,166 N/A N/A Sale
SCHROEDER MARK S officer: EVP, President-Diagnostics Lab officer: EVP, President-Diagnos..
Common Stock 188 N/A N/A Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 208 $236.33 $49,157 Option
CAVENEY BRIAN J officer: EVP, President of Diagnostics officer: EVP, President of Diag..
Restricted Stock Unit 2,870 N/A N/A Option
CAVENEY BRIAN J officer: EVP, President of Diagnostics officer: EVP, President of Diag..
Common Stock 2,870 N/A N/A Option
EISENBERG GLENN A officer: Chief Financial Officer, EVP officer: Chief Financial Office..
Restricted Stock Unit 1,720 N/A N/A Option
EISENBERG GLENN A officer: Chief Financial Officer, EVP officer: Chief Financial Office..
Restricted Stock Unit 1,720 N/A N/A Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Restricted Stock Unit 573 N/A N/A Option
BERBERIAN LANCE officer: EVP, CIO & CTO officer: EVP, CIO & CTO
Restricted Stock Unit 2,940 N/A N/A Option
EISENBERG GLENN A officer: Chief Financial Officer, EVP officer: Chief Financial Office..
Common Stock 1,720 N/A N/A Option
SCHROEDER MARK S officer: EVP, President-Diagnostics Lab officer: EVP, President-Diagnos..
Restricted Stock Unit 517 N/A N/A Option
SCHROEDER MARK S officer: EVP, President-Diagnostics Lab officer: EVP, President-Diagnos..
Restricted Stock Unit 517 N/A N/A Option
BERBERIAN LANCE officer: EVP, CIO & CTO officer: EVP, CIO & CTO
Common Stock 2,940 N/A N/A Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer officer: EVP, Chief Legal Officer
Common Stock 573 N/A N/A Option
SCHROEDER MARK S officer: EVP, President-Diagnostics Lab officer: EVP, President-Diagnos..
Common Stock 517 N/A N/A Option
BERBERIAN LANCE officer: EVP, CIO & CTO officer: EVP, CIO & CTO
Common Stock 2,940 N/A N/A Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Common Stock 867 N/A N/A Option
WILKINSON PETER J officer: SVP, Chief Accounting Officer officer: SVP, Chief Accounting ..
Restricted Stock Unit 867 $73.3 $63,547 Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Restricted Stock Unit 581 N/A N/A Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Development officer: CEO, Covance Drug Deve..
Common Stock 581 N/A N/A